Protara Therapeutics, Inc. Operating Leases, Rent Expense
Protara Therapeutics, Inc. (TARA) reported Operating Leases, Rent Expense of $300.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2019-03-13
- Protara Therapeutics, Inc. operating leases, rent expense for the quarter ending 2016-12-31 was $64.00K, a 4.92% increase year-over-year.
- Protara Therapeutics, Inc. operating leases, rent expense for the quarter ending 2016-09-30 was $45.00K, a 2.17% decline year-over-year.
- Protara Therapeutics, Inc. operating leases, rent expense for the quarter ending 2016-06-30 was $46.00K, a 0.00% change year-over-year.
- Protara Therapeutics, Inc. operating leases, rent expense for the quarter ending 2016-03-31 was $45.00K, a 4.26% decline year-over-year.
- Protara Therapeutics, Inc. operating leases, rent expense for fiscal 2018 was $300.00K, a 50.00% increase from fiscal 2017.
- Protara Therapeutics, Inc. operating leases, rent expense for fiscal 2017 was $200.00K, a 0.00% change from fiscal 2016.
- Protara Therapeutics, Inc. operating leases, rent expense for fiscal 2016 was $200.00K, a 0.00% change from fiscal 2015.
- Protara Therapeutics, Inc. operating leases, rent expense for fiscal 2015 was $200.00K, a 0.00% change from fiscal 2014.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 3 month as first filed | Operating Leases, Rent Expense 6 month | Operating Leases, Rent Expense 9 month | Operating Leases, Rent Expense 12 month |
|---|---|---|---|---|---|
| 2018-12-31 | $300.00K 10-K · filed 2019-03-13 | ||||
| 2017-12-31 | $200.00K 10-K · filed 2019-03-13 | ||||
| 2016-12-31 | $64.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $109.00K derived: sum of 2 quarters · filed 2019-03-13 | $155.00K derived: sum of 3 quarters · filed 2019-03-13 | $200.00K 10-K · filed 2019-03-13 | |
| 2016-09-30 | $45.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $91.00K derived: sum of 2 quarters · filed 2016-11-07 | $136.00K 10-Q · filed 2016-11-07 | $197.00K derived: sum of 4 quarters · filed 2018-03-14 | |
| 2016-06-30 | $46.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $91.00K 10-Q · filed 2016-08-08 | $152.00K derived: sum of 3 quarters · filed 2018-03-14 | $198.00K derived: sum of 4 quarters · filed 2018-03-14 | |
| 2016-03-31 | $45.00K 10-Q · filed 2016-05-09 | $106.00K derived: sum of 2 quarters · filed 2018-03-14 | $152.00K derived: sum of 3 quarters · filed 2018-03-14 | $198.00K derived: sum of 4 quarters · filed 2018-03-14 | |
| 2015-12-31 | $61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $107.00K derived: sum of 2 quarters · filed 2018-03-14 | $153.00K derived: sum of 3 quarters · filed 2018-03-14 | $200.00K 10-K · filed 2018-03-14 | |
| 2015-09-30 | $46.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $92.00K derived: sum of 2 quarters · filed 2016-11-07 | $139.00K 10-Q · filed 2016-11-07 | $200.00K derived: sum of 4 quarters · filed 2017-03-16 | |
| 2015-06-30 | $46.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $93.00K 10-Q · filed 2016-08-08 | $154.00K derived: sum of 3 quarters · filed 2017-03-16 | $200.00K derived: sum of 4 quarters · filed 2017-03-16 | |
| 2015-03-31 | $47.00K 10-Q · filed 2016-05-09 | $46.00K 10-Q · filed 2015-05-13 | $108.00K derived: sum of 2 quarters · filed 2017-03-16 | $154.00K derived: sum of 3 quarters · filed 2017-03-16 | $200.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2014-12-31 | $61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $107.00K derived: sum of 2 quarters · filed 2017-03-16 | $153.00K derived: sum of 3 quarters · filed 2017-03-16 | $200.00K 10-K · filed 2017-03-16 | |
| 2014-09-30 | $46.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $92.00K derived: sum of 2 quarters · filed 2015-11-12 | $139.00K 10-Q · filed 2015-11-12 | ||
| 2014-06-30 | $46.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $93.00K 10-Q · filed 2015-08-13 | |||
| 2014-03-31 | $47.00K 10-Q · filed 2015-05-13 | ||||
| 2013-12-31 | $200.00K 10-K · filed 2016-03-14 | ||||
| 2012-12-31 | $300.00K 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |